This page shows the latest HER2-positive non-small cell lung cancer news and features for those working in and with pharma, biotech and healthcare.
Merck &Co (MSD) has agreed to acquire VelosBio for $2.75bn, giving MSD access to a number of potential cancer treatments in the process. ... breast cancer (TNBC), hormone receptor-positive and/or HER2-positive breast cancer and non-squamous non-small
The trial is particularly disappointing as Kadcyla parent Herceptin has previously been shown to be effective in HER2-positive gastric cancer, and has been approved for this use for several years. ... expand its use into early breast cancer and is also
Roche's Avastin has added to its long list of approved indications with a green light in the EU to treat cervical cancer. . ... It is also in trials for additional indications including adjuvant treatment of HER2-positive and HER2-negative breast cancer
More from news
Approximately 0 fully matching, plus 3 partially matching documents found.
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...